[go: up one dir, main page]

DK0585368T3 - Implanterbart biokompatibelt immunisolatorisk vehikel til afgivelse af udvalgte terapeutiske produkter - Google Patents

Implanterbart biokompatibelt immunisolatorisk vehikel til afgivelse af udvalgte terapeutiske produkter

Info

Publication number
DK0585368T3
DK0585368T3 DK92912606.8T DK92912606T DK0585368T3 DK 0585368 T3 DK0585368 T3 DK 0585368T3 DK 92912606 T DK92912606 T DK 92912606T DK 0585368 T3 DK0585368 T3 DK 0585368T3
Authority
DK
Denmark
Prior art keywords
vehicle
individual
delivery
cells
immunoisolatory
Prior art date
Application number
DK92912606.8T
Other languages
Danish (da)
English (en)
Inventor
Patrick Aebischer
Keith E Dionne
Dwaine F Emerich
Diane Hoffman
David W Scharp
Paul E Lacy
Paul R Sanberg
Lisa Christenson
Orion D Hegre
Alfred V Vasconcellos
Michael J Lysaght
Frank T Gentile
Original Assignee
Univ Brown Res Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Brown Res Found filed Critical Univ Brown Res Found
Application granted granted Critical
Publication of DK0585368T3 publication Critical patent/DK0585368T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0092—Hollow drug-filled fibres, tubes of the core-shell type, coated fibres, coated rods, microtubules or nanotubes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/30—Nerves; Brain; Eyes; Corneal cells; Cerebrospinal fluid; Neuronal stem cells; Neuronal precursor cells; Glial cells; Oligodendrocytes; Schwann cells; Astroglia; Astrocytes; Choroid plexus; Spinal cord tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/37—Digestive system
    • A61K35/39—Pancreas; Islets of Langerhans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A61K38/185—Nerve growth factor [NGF]; Brain derived neurotrophic factor [BDNF]; Ciliary neurotrophic factor [CNTF]; Glial derived neurotrophic factor [GDNF]; Neurotrophins, e.g. NT-3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4816—Wall or shell material
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/0012—Cell encapsulation
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/0062—General methods for three-dimensional culture
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0613—Cells from endocrine organs
    • C12N5/0614—Adrenal gland
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
    • C12N5/0656—Adult fibroblasts
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0676—Pancreatic cells
    • C12N5/0677—Three-dimensional culture, tissue culture or organ culture; Encapsulated cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K2035/126—Immunoprotecting barriers, e.g. jackets, diffusion chambers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K2035/126—Immunoprotecting barriers, e.g. jackets, diffusion chambers
    • A61K2035/128—Immunoprotecting barriers, e.g. jackets, diffusion chambers capsules, e.g. microcapsules
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2510/00—Genetically modified cells
    • C12N2510/02—Cells for production

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Cell Biology (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Virology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Endocrinology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Diabetes (AREA)
  • Molecular Biology (AREA)
  • Psychology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Urology & Nephrology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Dermatology (AREA)
  • Physiology (AREA)
DK92912606.8T 1991-04-25 1992-04-22 Implanterbart biokompatibelt immunisolatorisk vehikel til afgivelse af udvalgte terapeutiske produkter DK0585368T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US69240391A 1991-04-25 1991-04-25

Publications (1)

Publication Number Publication Date
DK0585368T3 true DK0585368T3 (da) 1998-03-16

Family

ID=24780436

Family Applications (1)

Application Number Title Priority Date Filing Date
DK92912606.8T DK0585368T3 (da) 1991-04-25 1992-04-22 Implanterbart biokompatibelt immunisolatorisk vehikel til afgivelse af udvalgte terapeutiske produkter

Country Status (14)

Country Link
US (10) US5800828A (fr)
EP (1) EP0585368B1 (fr)
JP (2) JP4215273B2 (fr)
AT (1) ATE156344T1 (fr)
AU (2) AU666118B2 (fr)
CA (1) CA2109085C (fr)
DE (1) DE69221484T2 (fr)
DK (1) DK0585368T3 (fr)
ES (1) ES2107537T3 (fr)
FI (1) FI934545A7 (fr)
GR (1) GR3025301T3 (fr)
NO (1) NO308198B1 (fr)
SG (1) SG47470A1 (fr)
WO (1) WO1992019195A1 (fr)

Families Citing this family (505)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5786216A (en) * 1987-11-17 1998-07-28 Cytotherapeutics, Inc. Inner-supported, biocompatible cell capsules
ES2107537T3 (es) * 1991-04-25 1997-12-01 Univ Brown Res Found Vehiculo inmunoaislante biocompatible implantable para suministrar productos terapeuticos seleccionados.
US5824331A (en) * 1992-02-24 1998-10-20 Encelle, Inc. Bioartificial devices and cellular matrices therefor
US6352707B1 (en) 1992-02-24 2002-03-05 Anton-Lewis Usala Transplant encapsulation in a hydrogel matrix to obscure immune recognition
US5830492A (en) * 1992-02-24 1998-11-03 Encelle, Inc. Bioartificial devices and cellular matrices therefor
US5834005A (en) * 1992-02-24 1998-11-10 Encelle, Inc. Bioartificial devices and cellular matrices therefor
US6231881B1 (en) 1992-02-24 2001-05-15 Anton-Lewis Usala Medium and matrix for long-term proliferation of cells
WO1994010950A1 (fr) * 1992-11-16 1994-05-26 Brown University Research Foundation Macrocapsules microporeuses
US5709854A (en) * 1993-04-30 1998-01-20 Massachusetts Institute Of Technology Tissue formation by injecting a cell-polymeric solution that gels in vivo
CA2147626C (fr) * 1993-08-10 1998-04-21 Mark D. Butler Dispositif d'encapsulation de cellules
EP1179350A3 (fr) * 1993-08-12 2003-01-02 Cytotherapeutics, Inc. Système cellulaire encapsulé pour implantation dans le SNC hunain
US5908623A (en) 1993-08-12 1999-06-01 Cytotherapeutics, Inc. Compositions and methods for the delivery of biologically active molecules using genetically altered cells contained in biocompatible immunoisolatory capsules
US5534404A (en) * 1993-12-10 1996-07-09 Cytotherapeutics, Inc. Glucose responsive insulin secreting β-cell lines and method for producing same
US5550050A (en) * 1994-04-15 1996-08-27 Cytotherapeutics, Inc. Method for implanting encapsulated cells in a host
AU779272B2 (en) * 1994-04-25 2005-01-13 Genentech Inc. Biologically active substance-secreting hybrid gel
DE69531712T2 (de) * 1994-04-25 2004-07-01 Japan Science And Technology Corp., Kawaguchi Hybridgel, das eine biologisch aktive Substanz sekretiert
US6703017B1 (en) 1994-04-28 2004-03-09 Ixion Biotechnology, Inc. Reversal of insulin-dependent diabetes by islet-producing stem cells, islet progenitor cells and islet-like structures
US5935849A (en) * 1994-07-20 1999-08-10 Cytotherapeutics, Inc. Methods and compositions of growth control for cells encapsulated within bioartificial organs
US5840576A (en) * 1994-07-20 1998-11-24 Cytotherapeutics, Inc. Methods and compositions of growth control for cells encapsulated within bioartificial organs
US5834029A (en) * 1994-07-20 1998-11-10 Cytotherapeutics, Inc. Nerve guidance channel containing bioartificial three-dimensional hydrogel extracellular matrix derivatized with cell adhesive peptide fragment
US5853385A (en) * 1994-08-26 1998-12-29 Cytotherapeutics, Inc. Encapsulated PC12 cell transplants for treatment of Parkinson's disease
FR2724320B1 (fr) * 1994-09-13 1996-12-20 Transgene Sa Nouvel implant pour le traitement des maladies acquises
US20030152909A1 (en) * 1994-11-16 2003-08-14 Mitrani Eduardo N. In vitro micro-organs, and uses related thereto
WO2003035851A1 (fr) * 2001-10-23 2003-05-01 Yissum Research Development Company Of The Hebrew University Of Jerusalem Micro-organes in vitro, et utilisations correspondantes
US6126936A (en) * 1995-03-10 2000-10-03 Biohybrid Technologies Llc Microcapsules and composite microreactors for immunoisolation of cells
US5830460A (en) 1995-03-13 1998-11-03 University Of South Florida Sertoli cells as transplantation facilitator for cell transplantation
US6495364B2 (en) * 1995-05-23 2002-12-17 Neurotech, S.A. Mx-1 conditionally immortalized cells
US5681740A (en) * 1995-06-05 1997-10-28 Cytotherapeutics, Inc. Apparatus and method for storage and transporation of bioartificial organs
US5741685A (en) * 1995-06-07 1998-04-21 Children's Medical Center Corporation Parenchymal cells packaged in immunoprotective tissue for implantation
US5837234A (en) * 1995-06-07 1998-11-17 Cytotherapeutics, Inc. Bioartificial organ containing cells encapsulated in a permselective polyether suflfone membrane
AU6854696A (en) * 1995-09-22 1997-04-09 Gore Hybrid Technologies, Inc. Improved cell encapsulation device
AU7204996A (en) * 1995-10-02 1997-04-28 Cytotherapeutics, Inc. Method for treating amyotrophic lateral sclerosis
US6283951B1 (en) * 1996-10-11 2001-09-04 Transvascular, Inc. Systems and methods for delivering drugs to selected locations within the body
WO1997015243A1 (fr) 1995-10-26 1997-05-01 Latta Paul P Induction d'une tolerance immunologique
US6299895B1 (en) 1997-03-24 2001-10-09 Neurotech S.A. Device and method for treating ophthalmic diseases
US5672361A (en) * 1996-03-29 1997-09-30 Desmos, Inc. Laminin 5 for growth of pancreatic islet cells
US6224912B1 (en) 1996-04-03 2001-05-01 The Rogo Institute Cancer-cell proliferation-suppressing material produced by cancer cells restricted by entrapment
US7297331B2 (en) * 1996-04-03 2007-11-20 The Rogosin Institute Beads containing restricted cancer cells producing material suppressing cancer cell proliferation
WO1997038707A1 (fr) * 1996-04-17 1997-10-23 Cytotherapeutics, Inc. Procede et dispositif servant a administrer des molecules provoquant l'apoptose
US6027721A (en) * 1996-05-20 2000-02-22 Cytotherapeutics, Inc. Device and method for encapsulated gene therapy
IL118376A0 (en) * 1996-05-22 1996-09-12 Univ Ben Gurion Polysaccharide sponges for cell culture and transplantation
US6054142A (en) * 1996-08-01 2000-04-25 Cyto Therapeutics, Inc. Biocompatible devices with foam scaffolds
FR2753086B1 (fr) * 1996-09-12 1999-02-26 Hospal R & D Int Dispositif et procede de fabrication d'une capsule tubulaire segmentee contenant un milieu biologiquement actif
US6458574B1 (en) 1996-09-12 2002-10-01 Transkaryotic Therapies, Inc. Treatment of a α-galactosidase a deficiency
US6083725A (en) * 1996-09-13 2000-07-04 Transkaryotic Therapies, Inc. Tranfected human cells expressing human α-galactosidase A protein
US6200589B1 (en) 1996-09-13 2001-03-13 The University Of Akron Biological implants of semipermeable amphiphilic membranes
US6156728A (en) * 1996-11-01 2000-12-05 Genentech, Inc. Treatment of inner ear hair cells
US6593290B1 (en) 1996-11-01 2003-07-15 Genentech, Inc. Treatment of inner ear hair cells
US5952226A (en) * 1996-11-05 1999-09-14 Modex Therapeutiques Hypoxia responsive EPO producing cells
US9155496B2 (en) 1997-03-04 2015-10-13 Dexcom, Inc. Low oxygen in vivo analyte sensor
US7899511B2 (en) 2004-07-13 2011-03-01 Dexcom, Inc. Low oxygen in vivo analyte sensor
US6121415A (en) 1997-07-09 2000-09-19 Genentech, Inc. ErbB4 receptor-specific neuregolin related ligands and uses therefor
ZA986077B (en) 1997-07-09 2000-01-10 Genentech Inc ErbB4 receptor-specific neuregulin related ligands and uses therefor.
WO1999005502A2 (fr) * 1997-07-22 1999-02-04 The General Hospital Corporation Modulation des agregats multicellulaires par la contrainte exercee par des solides
US6994856B1 (en) 1997-07-24 2006-02-07 Genentech, Inc. ErbB4 receptor-specific neuregulin related ligands and uses therefor
US6287558B1 (en) * 1997-08-01 2001-09-11 Biohybrio Technologies Llc Devices containing cells or tissue and an agent that inhibits damage by a host cell molecule
US6368612B1 (en) 1997-12-12 2002-04-09 Biohybrid Technologies Llc Devices for cloaking transplanted cells
US7687057B2 (en) 1998-01-09 2010-03-30 Yissum Research Development Company Of The Hebrew University Of Jerusalem In vitro micro-organs, and uses related thereto
US5922339A (en) * 1998-01-27 1999-07-13 Usala; Anton-Lewis Compositions and methods for biocompatible implants
US6872387B1 (en) 1998-02-24 2005-03-29 The Regents Of The University Of Michigan Three-dimensional hydrogel/cell system
US20050208114A1 (en) * 1998-03-24 2005-09-22 Petito George D Composition and method for healing tissues
US7691829B2 (en) * 1998-03-24 2010-04-06 Petito George D Composition and method for healing tissues
US6303136B1 (en) 1998-04-13 2001-10-16 Neurotech S.A. Cells or tissue attached to a non-degradable filamentous matrix encapsulated by a semi-permeable membrane
US6175752B1 (en) 1998-04-30 2001-01-16 Therasense, Inc. Analyte monitoring device and methods of use
US8465425B2 (en) 1998-04-30 2013-06-18 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US6949816B2 (en) 2003-04-21 2005-09-27 Motorola, Inc. Semiconductor component having first surface area for electrically coupling to a semiconductor chip and second surface area for electrically coupling to a substrate, and method of manufacturing same
US8688188B2 (en) 1998-04-30 2014-04-01 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8480580B2 (en) 1998-04-30 2013-07-09 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8974386B2 (en) 1998-04-30 2015-03-10 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8346337B2 (en) 1998-04-30 2013-01-01 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US9066695B2 (en) 1998-04-30 2015-06-30 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
AU3728099A (en) * 1998-05-14 1999-11-29 Steven A. Goldman Specially devised neuronal implants for reconstruction of damaged central nervous system
WO1999060105A1 (fr) * 1998-05-15 1999-11-25 Modex Therapeutiques, S.A. Dispositif d'encapsulation cellulaire a membrane plane
MXPA00000009A (es) 1998-06-22 2005-09-08 Autologous Wound Therapy Inc Solicitud para patente de utilidad para curativo de heridas mejorado enriquecido con plaquetas.
US6593133B1 (en) 1998-07-06 2003-07-15 Nsgene A/S Neurotrophic factors
NO983911D0 (no) * 1998-08-26 1998-08-26 Norsk Hydro As Alginatkapsler til bruk ved behandling av hjernesvulst
WO2000029206A1 (fr) * 1998-11-13 2000-05-25 Sensor Technologies Inc. Preparations monodispersees utiles pour des protheses
US6713293B1 (en) 1999-02-08 2004-03-30 Friedrich Grummt Encapsulated cells containing an amplified expression vector as a drug delivery device
US6903244B1 (en) 1999-02-26 2005-06-07 University Of Utah Research Foundation Mice which are +/− or −/− for the elastin gene as models for vascular disease
US6495161B1 (en) * 1999-03-09 2002-12-17 Vivorx, Inc. Cytoprotective biocompatible containment systems for biologically active materials and methods of making same
US6303355B1 (en) 1999-03-22 2001-10-16 Duke University Method of culturing, cryopreserving and encapsulating pancreatic islet cells
US6365385B1 (en) 1999-03-22 2002-04-02 Duke University Methods of culturing and encapsulating pancreatic islet cells
US6361771B1 (en) 1999-04-06 2002-03-26 Neurotech S.A. ARPE-19 as a platform cell line for encapsulated cell-based delivery
US20090047325A1 (en) * 1999-04-30 2009-02-19 Neurotrophincell Pty. Limited Xenotransplant for cns therapy
AU4440000A (en) * 1999-04-30 2000-11-17 Diatranz Limited Xenotransplant for cns therapy
US20050265977A1 (en) * 1999-04-30 2005-12-01 Elliott Robert B Xenotransplant for CNS therapy
US20040213768A1 (en) * 1999-04-30 2004-10-28 Elliott Robert Bartlett Preparation for biotransplantation and xenotransplantion and uses thereof
US6558665B1 (en) * 1999-05-18 2003-05-06 Arch Development Corporation Encapsulating particles with coatings that conform to size and shape of the particles
US6471689B1 (en) * 1999-08-16 2002-10-29 Thomas Jefferson University Implantable drug delivery catheter system with capillary interface
WO2001023528A1 (fr) * 1999-09-27 2001-04-05 University Of Florida Research Foundation Inversion de diabetes dependant de l'insuline par des cellules souches insulaires, des cellules insulaires progenitrices et des structures de type insulaire
DE60030310T2 (de) * 1999-10-20 2007-08-23 Gentra Systems Inc., Minneapolis Mix- und giessapparat mit drehbarem arm und zugehörigem gefäss
US6878543B1 (en) 1999-10-25 2005-04-12 Nsgene Sa Cultures of GFAP+ nestin+ cells that differentiate to neurons
US6365171B1 (en) 1999-11-04 2002-04-02 The University Of Akron Amphiphilic networks, implantable immunoisolatory devices and methods of preparation
US8012500B2 (en) 2000-01-01 2011-09-06 Beta-O2 Technologies Ltd. Implantable device
EP1248640B1 (fr) * 2000-01-20 2006-10-04 Diabcell Pty Limited Preparation et xenotransplantation d'ilots de porc
US20020106346A1 (en) * 2000-03-06 2002-08-08 Shah Kumarpal A. Immune modulation with polystyrene sulfonate
US20030167054A1 (en) * 2000-05-05 2003-09-04 Lawrence Rosenberg Device for cell implantation
CA2410968C (fr) 2000-05-31 2011-03-29 Encelle, Inc. Traitement des ulceres chroniques
US6730016B1 (en) * 2000-06-12 2004-05-04 Acorn Cardiovascular, Inc. Cardiac disease treatment and device
US20050095268A1 (en) * 2000-06-12 2005-05-05 Acorn Cardiovascular, Inc. Cardiac wall tension relief with cell loss management
DK1333846T3 (da) * 2000-10-17 2012-08-06 Diatranz Otsuka Ltd Fremstilling og xenotransplantation af porcine øer
US6560471B1 (en) 2001-01-02 2003-05-06 Therasense, Inc. Analyte monitoring device and methods of use
US7442370B2 (en) 2001-02-01 2008-10-28 Biogen Idec Ma Inc. Polymer conjugates of mutated neublastin
US7232425B2 (en) * 2001-03-02 2007-06-19 Sorenson Development, Inc. Apparatus and method for specific interstitial or subcutaneous diffusion and dispersion of medication
US7276580B2 (en) 2001-03-12 2007-10-02 Biogen Idec Ma Inc. Neurotrophic factors
US7252982B2 (en) * 2001-03-15 2007-08-07 Massachusetts Institute Of Technology Tissue engineering enhanced by the transfer of a growth factor gene
US20030073608A1 (en) * 2001-04-10 2003-04-17 Woolf Nancy J. Process for treating disease
CA2388723C (fr) * 2001-06-06 2012-10-23 Becton, Dickinson & Company Methode de formation d'une matrice extracellulaire prete a l'emploi, a repartition uniforme, sur un support
EP1411989A4 (fr) * 2001-06-08 2006-11-29 Boehringer Ingelheim Pharma Procedes d'amelioration de l'activite de lignees cellulaires dans des dispositifs d'immunoisolation
ATE354175T1 (de) * 2001-06-12 2007-03-15 Akrion Technologies Inc Megaschallreinigungs- und trocknungsvorrichtung
US7858679B2 (en) * 2001-07-20 2010-12-28 Northwestern University Polymeric compositions and related methods of use
US7618937B2 (en) * 2001-07-20 2009-11-17 Northwestern University Peptidomimetic polymers for antifouling surfaces
US8815793B2 (en) * 2001-07-20 2014-08-26 Northwestern University Polymeric compositions and related methods of use
EP1281767A3 (fr) 2001-07-31 2003-05-28 Aladar A. Szalay Microbes et cellules lumineuses pour le diagnostic et le traitement des tumeurs
MXPA04002476A (es) 2001-09-14 2004-05-31 Anthony A Boiarski Dispositivo de nanoporo microfabricado para la liberacion sostenida de agente terapeutico.
EP1438395B1 (fr) * 2001-09-28 2011-11-30 Diabcell Pty Limited Croissance d'une matiere pour xenotransplant dans une culture
US7988685B2 (en) * 2001-11-01 2011-08-02 Regents Of The University Of Minnesota Hydrogel compositions, devices, and microscale components
KR100969344B1 (ko) * 2001-11-05 2010-07-09 메드제닉스 인코포레이티드 조직 기재 치료를 위한 폐쇄된 자동화 시스템, 이를 이용한 투약 및 투여 방법
US8088568B2 (en) 2001-11-05 2012-01-03 Medgentics, Inc. Dermal micro-organs, methods and apparatuses for producing and using the same
US8501396B2 (en) 2001-11-05 2013-08-06 Medgenics Medical Israel Ltd. Dermal micro-organs, methods and apparatuses for producing and using the same
US7468242B2 (en) 2001-11-05 2008-12-23 Medgenics, Inc. Dermal micro organs, methods and apparatuses for producing and using the same
NZ515310A (en) * 2001-11-07 2004-08-27 Diabcell Pty Ltd Methods of treatment and delivery modes
AU2002365162A1 (en) * 2001-11-14 2003-07-09 Northwestern University Self-assembly and mineralization of peptide-amphiphile nanofibers
AU2002351164A1 (en) * 2001-11-26 2003-06-10 Molecular Reflections, Inc. Microscale immobilization of molecules using a hydrogel and methods of use thereof
US7613491B2 (en) 2002-05-22 2009-11-03 Dexcom, Inc. Silicone based membranes for use in implantable glucose sensors
US8364229B2 (en) 2003-07-25 2013-01-29 Dexcom, Inc. Analyte sensors having a signal-to-noise ratio substantially unaffected by non-constant noise
US9282925B2 (en) 2002-02-12 2016-03-15 Dexcom, Inc. Systems and methods for replacing signal artifacts in a glucose sensor data stream
US8260393B2 (en) 2003-07-25 2012-09-04 Dexcom, Inc. Systems and methods for replacing signal data artifacts in a glucose sensor data stream
US9247901B2 (en) 2003-08-22 2016-02-02 Dexcom, Inc. Systems and methods for replacing signal artifacts in a glucose sensor data stream
US8010174B2 (en) 2003-08-22 2011-08-30 Dexcom, Inc. Systems and methods for replacing signal artifacts in a glucose sensor data stream
US7379765B2 (en) 2003-07-25 2008-05-27 Dexcom, Inc. Oxygen enhancing membrane systems for implantable devices
US7371719B2 (en) * 2002-02-15 2008-05-13 Northwestern University Self-assembly of peptide-amphiphile nanofibers under physiological conditions
EP1476202B1 (fr) 2002-02-21 2009-01-14 Encelle, Inc. Matrices d'hydrogel bioactif reticule
US20080086792A1 (en) 2006-10-13 2008-04-17 Thomas Charles Kuracina Method and apparatus for diverting sweat, liquid, moisture or the like from an eye
US20030170278A1 (en) * 2002-03-11 2003-09-11 Wolf David E. Microreactor and method of determining a microreactor suitable for a predetermined mammal
BR122017016940B8 (pt) * 2002-04-25 2021-07-27 Transkaryotic Therapies Inc método para preparação de uma composição farmacêutica compreendendo alfa-galactosidase a
KR20050009997A (ko) * 2002-05-08 2005-01-26 더 보드 오브 트러스티스 오브 더 리랜드 스탠포드 주니어 유니버시티 관이 배열되어 있는 나노튜브 매트
US20050008629A1 (en) * 2002-05-08 2005-01-13 Interpore Orthopaedics, A Delaware Corporation Encapsulated AGF cells
ATE449838T1 (de) 2002-05-16 2009-12-15 Absorber Ab Verfahren für donorspezifisches crossmatching
US20030228261A1 (en) * 2002-06-05 2003-12-11 Aladar Szalay Light emitting microorganisms and cells for diagnosis and therapy of diseases associated with wounded or inflamed tissue
EP1369491A1 (fr) * 2002-06-05 2003-12-10 Aladar A. Szalay Microorganismes et cellules luminescents pour le diagnostic et la thérapie de maladies asociées avec du tissu blessé ou inflammé
AU2003242967A1 (en) * 2002-07-12 2004-02-02 Yissum Research Development Company Of The Hebrew University Of Jerusalem Method and device for inducing biological processes by micro-organs
US8911831B2 (en) * 2002-07-19 2014-12-16 Northwestern University Surface independent, surface-modifying, multifunctional coatings and applications thereof
US7163545B2 (en) * 2002-07-29 2007-01-16 Mayo Foundation For Medical Education And Research Spinal cord surgical implant
US7534761B1 (en) 2002-08-21 2009-05-19 North Western University Charged peptide-amphiphile solutions and self-assembled peptide nanofiber networks formed therefrom
US20050069572A1 (en) * 2002-10-09 2005-03-31 Jennifer Elisseeff Multi-layered polymerizing hydrogels for tissue regeneration
JP4571776B2 (ja) * 2002-11-05 2010-10-27 Ｊｘ日鉱日石エネルギー株式会社 潤滑油組成物
US7554021B2 (en) 2002-11-12 2009-06-30 Northwestern University Composition and method for self-assembly and mineralization of peptide amphiphiles
US7683025B2 (en) * 2002-11-14 2010-03-23 Northwestern University Synthesis and self-assembly of ABC triblock bola peptide amphiphiles
WO2006002283A1 (fr) * 2004-06-21 2006-01-05 Medtronic, Inc. Systemes et procedes medicaux permettant l'administration de compositions a des cellules
AU2002952993A0 (en) 2002-11-29 2002-12-12 The Corporation Of The Trustees Of The Order Of The Sisters Of Mercy In Queensland Therapeutic and diagnostic agents
WO2004058305A2 (fr) * 2002-12-24 2004-07-15 An-Go-Gen Inc. Therapie d'encapsulation de cellule
KR100486367B1 (ko) * 2003-01-14 2005-04-29 학교법인연세대학교 외벽에 반투막이 형성된 생분해성 이중 다공성 스캐폴드및 이를 이용한 조직세포 배양방법
BRPI0407001A (pt) 2003-01-31 2006-01-10 Sinai School Medicine Método para aumentar a estabilidade de uma proteìna purificada, uso de uma proteìna ligante sìtio-especìfica ativa, método para aumentar a produção de uma proteìna recombinante e composição farmacêutica
EP1606065A4 (fr) 2003-02-11 2010-09-29 Univ Northwestern Procedes et matieres pour revetements de surface nanocristallins et liaison de nanofibres d'amphiphiles peptidiques sur ceux-ci
AU2004233079B2 (en) 2003-04-18 2009-09-17 Biogen Ma Inc. Polymer-conjugated glycosylated neublastin
US7459152B2 (en) * 2003-04-23 2008-12-02 Rush University Medical Center Erythropoietin administration to improve graft survival
EP2377404A1 (fr) 2003-05-01 2011-10-19 Medgenics, Inc. Micro-organe dermique qui est un explant de tissus vivants
ATE478092T1 (de) 2003-06-10 2010-09-15 Nsgene As Verbesserte sekretion von neublastin
ATE420160T1 (de) * 2003-06-18 2009-01-15 Genelux Corp Modifizierte rekombinante vacciniaviren, verwendungen davon
AU2003238760B2 (en) * 2003-06-24 2008-07-31 Diatranz Otsuka Limited Porcine islets cultured with porcine sertoli cells for xenotransplantation
WO2007120442A2 (fr) 2003-07-25 2007-10-25 Dexcom, Inc. Système d'électrode double pour capteur d'analyte continu
US8423113B2 (en) 2003-07-25 2013-04-16 Dexcom, Inc. Systems and methods for processing sensor data
US9763609B2 (en) 2003-07-25 2017-09-19 Dexcom, Inc. Analyte sensors having a signal-to-noise ratio substantially unaffected by non-constant noise
US7651596B2 (en) 2005-04-08 2010-01-26 Dexcom, Inc. Cellulosic-based interference domain for an analyte sensor
US20190357827A1 (en) 2003-08-01 2019-11-28 Dexcom, Inc. Analyte sensor
US20100168657A1 (en) 2003-08-01 2010-07-01 Dexcom, Inc. System and methods for processing analyte sensor data
US7591801B2 (en) 2004-02-26 2009-09-22 Dexcom, Inc. Integrated delivery device for continuous glucose sensor
US8369919B2 (en) 2003-08-01 2013-02-05 Dexcom, Inc. Systems and methods for processing sensor data
US8886273B2 (en) 2003-08-01 2014-11-11 Dexcom, Inc. Analyte sensor
US7519408B2 (en) 2003-11-19 2009-04-14 Dexcom, Inc. Integrated receiver for continuous analyte sensor
US8160669B2 (en) 2003-08-01 2012-04-17 Dexcom, Inc. Transcutaneous analyte sensor
US8761856B2 (en) 2003-08-01 2014-06-24 Dexcom, Inc. System and methods for processing analyte sensor data
US8845536B2 (en) 2003-08-01 2014-09-30 Dexcom, Inc. Transcutaneous analyte sensor
US7986986B2 (en) 2003-08-01 2011-07-26 Dexcom, Inc. System and methods for processing analyte sensor data
US8060173B2 (en) 2003-08-01 2011-11-15 Dexcom, Inc. System and methods for processing analyte sensor data
US20080119703A1 (en) 2006-10-04 2008-05-22 Mark Brister Analyte sensor
US8275437B2 (en) 2003-08-01 2012-09-25 Dexcom, Inc. Transcutaneous analyte sensor
US7774145B2 (en) 2003-08-01 2010-08-10 Dexcom, Inc. Transcutaneous analyte sensor
US9135402B2 (en) 2007-12-17 2015-09-15 Dexcom, Inc. Systems and methods for processing sensor data
US20140121989A1 (en) 2003-08-22 2014-05-01 Dexcom, Inc. Systems and methods for processing analyte sensor data
US7920906B2 (en) 2005-03-10 2011-04-05 Dexcom, Inc. System and methods for processing analyte sensor data for sensor calibration
WO2005020677A1 (fr) 2003-08-29 2005-03-10 The Walter And Eliza Hall Institute Of Medical Research Procede de selection de modeles d'animaux parmi les animaux ayant ete soumis a la mutagenese, et utilisation de facteurs de transcription myb pour le criblage
SE526959C2 (sv) * 2003-10-02 2005-11-29 Tikomed Ab Bioartificellt implantat innefattande en semipermeabel barriär samt förfarande för reducering av risken för bildning av bindrväv vid implantatet efter implantering genom att barriären förses med en permeabel beläggning av bioaktiv metall
MXPA06004329A (es) 2003-10-20 2006-06-05 Nsgene As Terapia genica in vivo de enfermedad de parkinson.
WO2005046445A2 (fr) 2003-11-07 2005-05-26 University Of Connecticut Systemes de tissus artificiels et leurs utilisations
US9247900B2 (en) 2004-07-13 2016-02-02 Dexcom, Inc. Analyte sensor
US11633133B2 (en) 2003-12-05 2023-04-25 Dexcom, Inc. Dual electrode system for a continuous analyte sensor
CA2549164A1 (fr) * 2003-12-05 2005-06-23 Northwestern University Amphiphiles peptidiques a assemblage automatique et procedes associes d'administration de facteur de croissance
US8364231B2 (en) 2006-10-04 2013-01-29 Dexcom, Inc. Analyte sensor
WO2005056576A2 (fr) 2003-12-05 2005-06-23 Northwestern University Amphphiles peptides ramifies, composes epitopes les concernant, et certaines de leurs structures auto-assemblees
ATE480761T1 (de) 2003-12-05 2010-09-15 Dexcom Inc Kalibrationsmethoden für einen kontinuierlich arbeitenden analytsensor
US8287453B2 (en) 2003-12-05 2012-10-16 Dexcom, Inc. Analyte sensor
US8423114B2 (en) 2006-10-04 2013-04-16 Dexcom, Inc. Dual electrode system for a continuous analyte sensor
EP2301428B1 (fr) 2003-12-09 2016-11-30 Dexcom, Inc. Traitement de signal pour capteur d'analyte continu
AU2011204947B2 (en) * 2003-12-15 2013-05-09 Ethicon Endo-Surgery, Inc. Method and device for minimally invasive implantation of biomaterial
US7780973B2 (en) * 2003-12-15 2010-08-24 Ethicon Endo-Surgery, Inc. Method and device for minimally invasive implantation of biomaterial
EP1701736A4 (fr) 2003-12-24 2008-05-07 Inst Medical W & E Hall Agents therapeutiques et utilisations
US7364592B2 (en) * 2004-02-12 2008-04-29 Dexcom, Inc. Biointerface membrane with macro-and micro-architecture
WO2009048462A1 (fr) 2007-10-09 2009-04-16 Dexcom, Inc. Système d'administration d'insuline intégré avec un capteur de glucose en continu
US8808228B2 (en) 2004-02-26 2014-08-19 Dexcom, Inc. Integrated medicament delivery device for use with continuous analyte sensor
EP1737949B1 (fr) * 2004-03-09 2010-09-15 Absorber AB Cellules endotheliales progenitrices et leurs methodes d'utilisation
US20050208090A1 (en) * 2004-03-18 2005-09-22 Medtronic, Inc. Methods and systems for treatment of neurological diseases of the central nervous system
US9845344B2 (en) 2004-03-30 2017-12-19 Hoba Therapeutics Aps Therapeutic use of a growth factor, NsG33
US8792955B2 (en) 2004-05-03 2014-07-29 Dexcom, Inc. Transcutaneous analyte sensor
NZ551828A (en) 2004-05-12 2009-03-31 Inst Medical W & E Hall A method of cell isolating a homogenous population of mammary stem cells using specific cell surface marker proteins
US8452368B2 (en) 2004-07-13 2013-05-28 Dexcom, Inc. Transcutaneous analyte sensor
US20060016700A1 (en) 2004-07-13 2006-01-26 Dexcom, Inc. Transcutaneous analyte sensor
US20070045902A1 (en) 2004-07-13 2007-03-01 Brauker James H Analyte sensor
US8565848B2 (en) 2004-07-13 2013-10-22 Dexcom, Inc. Transcutaneous analyte sensor
US8886272B2 (en) 2004-07-13 2014-11-11 Dexcom, Inc. Analyte sensor
US7783333B2 (en) 2004-07-13 2010-08-24 Dexcom, Inc. Transcutaneous medical device with variable stiffness
US7654956B2 (en) 2004-07-13 2010-02-02 Dexcom, Inc. Transcutaneous analyte sensor
RU2401084C2 (ru) * 2004-07-29 2010-10-10 Юниверсити Оф Майами Гибридное устройство для клеточной терапии
ES2432556T3 (es) 2004-08-04 2013-12-04 Evonik Corporation Métodos para fabricar dispositivos de suministro y sus dispositivos
US8075904B2 (en) * 2004-08-11 2011-12-13 California Institute Of Technology High aspect ratio template and method for producing same for central and peripheral nerve repair
KR20110126732A (ko) 2004-08-19 2011-11-23 바이오겐 아이덱 엠에이 인코포레이티드 뉴블라스틴 변형체
NZ553420A (en) 2004-08-19 2010-02-26 Biogen Idec Inc Refolding transforming growth factor beta family proteins
US20060046960A1 (en) * 2004-09-02 2006-03-02 Mckay William F Controlled and directed local delivery of anti-inflammatory compositions
US20060046961A1 (en) * 2004-09-02 2006-03-02 Mckay William F Controlled and directed local delivery of anti-inflammatory compositions
US20060093639A1 (en) * 2004-10-29 2006-05-04 Starkebaum Warren L Method and device for destroying body tissue
CN101060849A (zh) 2004-11-17 2007-10-24 巴尔的摩马里兰大学 作为有效的siRNA载体的高分支HK肽
US20070009668A1 (en) * 2004-11-18 2007-01-11 Wyman Jason L Microencapsulation of particles in a polymer solution by selective withdrawal through a high viscosity low density fluid and subsequent crosslinking
GB2420976B (en) * 2004-11-19 2006-12-20 Zvi Finkelstein Therapeutic implant
US7833513B2 (en) 2004-12-03 2010-11-16 Rhode Island Hospital Treatment of Alzheimer's Disease
EP1838846A4 (fr) * 2005-01-21 2008-12-10 Univ Northwestern Méthodes et compositions d'encapsulation de cellules
CA2598251A1 (fr) * 2005-03-04 2006-09-14 Northwestern University Epitopes angiogeniques de liaison a l'heparine, amphiphiles peptidiques, compositions auto-assemblees et procedes d'utilisation associes
US8133178B2 (en) 2006-02-22 2012-03-13 Dexcom, Inc. Analyte sensor
US20090076360A1 (en) 2007-09-13 2009-03-19 Dexcom, Inc. Transcutaneous analyte sensor
EP1869162A1 (fr) 2005-04-01 2007-12-26 NsGene A/S Lignee cellulaire precurseur neurale immortalisee humaine
US8744546B2 (en) 2005-05-05 2014-06-03 Dexcom, Inc. Cellulosic-based resistance domain for an analyte sensor
US20060249381A1 (en) * 2005-05-05 2006-11-09 Petisce James R Cellulosic-based resistance domain for an analyte sensor
NZ536009A (en) 2005-04-18 2007-01-26 Neurotrophincell Pty Ltd Choroid plexus preparation and uses thereof
US20090075375A1 (en) * 2005-04-18 2009-03-19 Neurotrophincell Pty Limited Choroid plexus preparation and uses thereof
US7588775B2 (en) * 2005-04-23 2009-09-15 E-L Management Corp. Silicone elastomer exfoliating compositions
ES2653844T3 (es) * 2005-05-17 2018-02-09 Gloriana Therapeutics Sarl Un sistema de terapia implantable para tratar a un ser vivo con un factor activo
JP2008545657A (ja) 2005-05-17 2008-12-18 アミカス セラピューティックス インコーポレイテッド １−デオキシノジリマイシンおよび誘導体を用いるポンペ病の治療方法
NZ540597A (en) * 2005-06-08 2007-02-23 Neurotrophincell Pty Ltd A method for preventing the onset of type I diabetes comprising administering an implantable composition comprising living choroid plexus cells
US7782189B2 (en) * 2005-06-20 2010-08-24 Carestream Health, Inc. System to monitor the ingestion of medicines
US7616111B2 (en) 2005-06-20 2009-11-10 Carestream Health, Inc. System to monitor the ingestion of medicines
DK1910535T3 (en) 2005-06-24 2016-09-26 The Walter And Eliza Hall Inst Of Medical Res Therapeutic pro-apoptotic BH-3-like molecules and method of forming and / or selecting the same
WO2007016643A2 (fr) * 2005-08-01 2007-02-08 Mount Sinai School Of Medicine Of New York University Procédé visant à prolonger la longévité au moyen d’antagonistes de npc1l1
US8357666B2 (en) 2005-08-01 2013-01-22 Nupotential, Inc. Reprogramming a cell by inducing a pluripotent gene through RNA interference
CN103251449B (zh) * 2005-10-13 2016-03-02 斯恩蒂斯有限公司 载药包装物
US20070190165A1 (en) * 2005-10-21 2007-08-16 Brey Eric M Tissue-specific basement membrane gels
US20070116680A1 (en) * 2005-11-18 2007-05-24 Rensselaer Polytechnic Institute Stem cells within gel microenvironments
AU2006332971B2 (en) 2005-12-30 2013-03-07 Neurotech Usa, Inc. Micronized device for the delivery of biologically active molecules and methods of use thereof
US20070190036A1 (en) * 2006-01-04 2007-08-16 Seda Kizilel Microencapsulation of pancreatic islets within a thin coat of glucagon-like peptide-1 functionalized poly(ethylene glycol)
US9757061B2 (en) 2006-01-17 2017-09-12 Dexcom, Inc. Low oxygen in vivo analyte sensor
EP2004796B1 (fr) * 2006-01-18 2015-04-08 DexCom, Inc. Membranes pour détecteur d'analyte
US7732539B2 (en) * 2006-02-16 2010-06-08 National Science Foundation Modified acrylic block copolymers for hydrogels and pressure sensitive wet adhesives
TWI501774B (zh) 2006-02-27 2015-10-01 Biogen Idec Inc 神經性病症之治療
US20100056440A1 (en) * 2006-03-01 2010-03-04 Biogen Idec Ma Inc. Compositions and methods for administering gdnf ligand family proteins
WO2007102842A2 (fr) 2006-03-09 2007-09-13 Dexcom, Inc. Systèmes et procédés de traitement de données de capteur de substance à analyser
WO2007120381A2 (fr) 2006-04-14 2007-10-25 Dexcom, Inc. Capteur d'analytes
WO2007143225A2 (fr) 2006-06-07 2007-12-13 Abbott Diabetes Care, Inc. Système et procédé de surveillance d'un analyte
TW200819540A (en) 2006-07-11 2008-05-01 Genelux Corp Methods and compositions for detection of microorganisms and cells and treatment of diseases and disorders
EP2051726B1 (fr) 2006-07-18 2018-04-18 University of Utah Research Foundation Procédé pour traiter la douleur et rechercher systématiquement des composés analgésiques
EP2064251B1 (fr) 2006-08-04 2017-10-25 Kensey Nash Corporation Composés biomimétiques et leurs procédés de synthèse
WO2008091386A2 (fr) * 2006-08-04 2008-07-31 Northwestern University Matériau biomimétique modulaire complexe et adhésif, procédés et applications de ce dernier
JP5191489B2 (ja) 2006-08-23 2013-05-08 エスヴイアイピー ２ エルエルシー 摂食行動を変更するデバイス及び方法
EP2056759B1 (fr) * 2006-08-29 2015-01-14 The University of Akron Dispositifs implantables pour la production d'insuline
AU2007294858B2 (en) 2006-09-14 2011-05-12 Medgenics Medical Israel, Ltd Long lasting drug formulations
US8454948B2 (en) 2006-09-14 2013-06-04 Medgenics Medical Israel Ltd. Long lasting drug formulations
US20100047311A1 (en) * 2006-11-22 2010-02-25 Beta O2 Technologies Ltd. Protecting algae from body fluids
EP2104492B1 (fr) 2006-11-28 2017-11-22 Beta O2 Technologies Ltd. Alimentation en oxygène pour greffe de cellules et vascularisation
US7980000B2 (en) * 2006-12-29 2011-07-19 Applied Materials, Inc. Vapor dryer having hydrophilic end effector
WO2008089032A1 (fr) * 2007-01-11 2008-07-24 Northwestern University Revêtement résistant aux salissures et procédés de fabrication de ceux-ci
US8383092B2 (en) * 2007-02-16 2013-02-26 Knc Ner Acquisition Sub, Inc. Bioadhesive constructs
US8673286B2 (en) 2007-04-09 2014-03-18 Northwestern University DOPA-functionalized, branched, poly(aklylene oxide) adhesives
SG177941A1 (en) 2007-04-03 2012-02-28 Oxyrane Uk Ltd Glycosylation of molecules
US8076295B2 (en) * 2007-04-17 2011-12-13 Nanotope, Inc. Peptide amphiphiles having improved solubility and methods of using same
US8329655B2 (en) 2007-05-01 2012-12-11 Biogen Idec Ma Inc. Methods for increasing vascularization
US20200037874A1 (en) 2007-05-18 2020-02-06 Dexcom, Inc. Analyte sensors having a signal-to-noise ratio substantially unaffected by non-constant noise
WO2008149347A2 (fr) * 2007-06-04 2008-12-11 Svip 8 Llc Dispositifs ancrables dans un tissu
WO2009110917A1 (fr) * 2007-06-07 2009-09-11 Osteotherapeutics, L.L.C. Compositions de ciment osseux pour une utilisation en tant que supports de facteur de croissance et procédés de fabrication de celles-ci
WO2008154312A1 (fr) 2007-06-08 2008-12-18 Dexcom, Inc. Dispositif de distribution de médicament intégré pour une utilisation avec un capteur de substance à analyser en continu
JP5328780B2 (ja) * 2007-06-13 2013-10-30 エフ エム シー コーポレーション アルギネート被覆多糖ゲル含有発泡体複合物、その製法および用途
US20090004455A1 (en) * 2007-06-27 2009-01-01 Philippe Gravagna Reinforced composite implant
US8932619B2 (en) * 2007-06-27 2015-01-13 Sofradim Production Dural repair material
EP2205634A2 (fr) * 2007-08-08 2010-07-14 Biogen Idec MA, Inc. Anticorps anti-neublastine et leurs utilisations
US20090098055A1 (en) 2007-08-23 2009-04-16 Intrexon Corporation Methods and Compositions for Diagnosing Disease
US20090068250A1 (en) 2007-09-07 2009-03-12 Philippe Gravagna Bioresorbable and biocompatible compounds for surgical use
WO2009031154A2 (fr) 2007-09-07 2009-03-12 Beta O2 Technologies Ltd. Couche d'air pour soutenir des cellules
US8093038B2 (en) * 2007-09-17 2012-01-10 Illinois Institute Of Technology Apparatus and method for encapsulating pancreatic cells
WO2009043052A1 (fr) * 2007-09-27 2009-04-02 Columbia University Procédés et systèmes de formation de matériaux biocompatibles
EP2205249B1 (fr) 2007-09-28 2018-11-07 Intrexon Corporation Constructions et bioréacteurs de commutation de gène théapeutique destinés à l'expression de molécules biothérapeutiques, et utilisation de ceux-ci
US20090090214A1 (en) * 2007-10-04 2009-04-09 Chung Yuan Christian University Method for forming nano-scale metal particles
US8417312B2 (en) 2007-10-25 2013-04-09 Dexcom, Inc. Systems and methods for processing sensor data
US9308068B2 (en) 2007-12-03 2016-04-12 Sofradim Production Implant for parastomal hernia
US8038721B2 (en) * 2007-12-17 2011-10-18 Anna Love Soft tissue filler
US8290559B2 (en) 2007-12-17 2012-10-16 Dexcom, Inc. Systems and methods for processing sensor data
JP5502751B2 (ja) 2007-12-20 2014-05-28 エボニック コーポレイション 低残留溶媒濃度を有する微粒子を調製するためのプロセス
WO2009086535A2 (fr) * 2007-12-27 2009-07-09 The Trustees Of Columbia University In The City Of New York Systèmes et procédés de formation de matériaux de matrice extracellulaire comportant un motif
EP2252196A4 (fr) 2008-02-21 2013-05-15 Dexcom Inc Systèmes et procédés pour traiter, transmettre et afficher des données de détecteur
US8396528B2 (en) 2008-03-25 2013-03-12 Dexcom, Inc. Analyte sensor
US11730407B2 (en) 2008-03-28 2023-08-22 Dexcom, Inc. Polymer membranes for continuous analyte sensors
WO2009121026A1 (fr) 2008-03-28 2009-10-01 Dexcom, Inc. Membranes polymères pour capteurs de substance à analyser continus
US8583204B2 (en) 2008-03-28 2013-11-12 Dexcom, Inc. Polymer membranes for continuous analyte sensors
US8682408B2 (en) 2008-03-28 2014-03-25 Dexcom, Inc. Polymer membranes for continuous analyte sensors
WO2009125332A1 (fr) * 2008-04-07 2009-10-15 Peter Bromley Procédé nouveau et sans danger pour une immunisation contre des agents de maladies infectieuses
EP2276838A4 (fr) 2008-04-07 2012-02-01 Nupotential Inc Reprogrammation d'une cellule par induction d'un gène pluripotent par interférence arn
CA2726804C (fr) 2008-06-02 2021-12-28 Dana-Farber Cancer Institute, Inc. Peptides derives de xbp1, cd138 et cs1
EP2303390A4 (fr) * 2008-06-03 2011-11-30 Svip 8 Llc Dispositifs a ancrage tissulaire
WO2009156866A2 (fr) 2008-06-27 2009-12-30 Sofradim Production Implant biosynthétique pour réparation de tissu mou
CN102164611B (zh) 2008-07-24 2015-01-07 Ns基因公司 生长因子metrnl的治疗用途
JP5774989B2 (ja) 2008-08-13 2015-09-09 スメド−ティーエイ／ティーディー・エルエルシー 整形外科用ねじ
US9616205B2 (en) 2008-08-13 2017-04-11 Smed-Ta/Td, Llc Drug delivery implants
US20100042213A1 (en) * 2008-08-13 2010-02-18 Nebosky Paul S Drug delivery implants
US10842645B2 (en) 2008-08-13 2020-11-24 Smed-Ta/Td, Llc Orthopaedic implant with porous structural member
US20100042226A1 (en) * 2008-08-13 2010-02-18 Nebosky Paul S Orthopaedic implant with spatially varying porosity
US9700431B2 (en) 2008-08-13 2017-07-11 Smed-Ta/Td, Llc Orthopaedic implant with porous structural member
WO2010025386A1 (fr) * 2008-08-29 2010-03-04 Smed-Ta/Td, Llc Implant orthopédique
US9540630B2 (en) 2008-09-17 2017-01-10 Beta O2 Technologies Ltd. Optimization of alginate encapsulation of islets for transplantation
US9446168B2 (en) 2010-06-07 2016-09-20 Beta-O2 Technologies Ltd. Multiple-layer immune barrier for donor cells
EP4227675B1 (fr) 2008-09-19 2024-12-11 DexCom, Inc. Membrane contenant des particules et électrode particulaire pour capteurs d analytes
US8043271B2 (en) 2008-11-26 2011-10-25 Beta 02 Technologies Ltd. Apparatus for transportation of oxygen to implanted cells
EP3187581A1 (fr) 2008-12-23 2017-07-05 BOCO Silicon Valley, Inc. Populations cibles de cellules précurseurs d'oligodendrocytes et leurs procédés de fabrication et d'utilisation
WO2010083842A2 (fr) 2009-01-23 2010-07-29 Nsgene A/S Expression de neuropeptides dans des cellules mammaliennes
AU2010206374B2 (en) 2009-01-23 2013-01-17 Gloriana Therapeutics Sarl Improved cell lines and their use in encapsulated cell biodelivery
US9511093B2 (en) 2009-03-23 2016-12-06 The Texas A & M University System Compositions of mesenchymal stem cells to regenerate bone
US9446194B2 (en) 2009-03-27 2016-09-20 Dexcom, Inc. Methods and systems for promoting glucose management
US8940766B2 (en) 2009-04-09 2015-01-27 Amicus Therapeutics, Inc. Methods for preventing and/or treating lysosomal storage disorders
CA2758522A1 (fr) * 2009-04-13 2010-10-21 Northwestern University Nouvelles structures peptidiques pour la regeneration des cartilages et procedes pour les utiliser
BRPI0902039B8 (pt) 2009-06-09 2021-05-25 Anhanguera Educacional Ltda composição farmacêutica e uso de composição farmacêutica para o tratamento, profilaxia ou prevenção de doenças neoplásicas em humanos e animais
JP5850416B2 (ja) * 2009-06-19 2016-02-03 国立大学法人九州大学 細胞組織体の製造方法
FR2949688B1 (fr) 2009-09-04 2012-08-24 Sofradim Production Tissu avec picots revetu d'une couche microporeuse bioresorbable
US8858990B2 (en) * 2009-09-17 2014-10-14 The Ohio State University Capsule of thermogenic cells for treating a metabolic disease
CA2775077C (fr) * 2009-09-22 2018-05-01 Evonik Degussa Corporation Dispositifs d'implants presentant differentes configurations de charge de l'agent bioactif
CA2775938C (fr) 2009-09-29 2021-08-10 Oxyrane Uk Limited Hydrolyse de la liaison du mannose-1-phospho-6-mannose au phospho-6-mannose
CN102573860A (zh) 2009-10-02 2012-07-11 巴克斯特国际公司 用于治疗肾脏损伤的造血干细胞
RS54466B1 (en) 2009-10-19 2016-06-30 Amicus Therapeutics, Inc. NEW COMPOSITIONS FOR THE PREVENTION AND / OR TREATMENT OF Lysosomal Accumulation Disorders
MX340807B (es) 2009-10-19 2016-07-27 Amicus Therapeutics Inc Nuevas composiciones para prevenir y/o tratar trastornos degenerativos del sistema nervioso central.
US20110106062A1 (en) * 2009-11-05 2011-05-05 Ecole Polytechnique Federale De Lausanne System and Method For In Vivo Delivery of Antibodies and Fragments Thereof
US20130053550A1 (en) 2009-11-19 2013-02-28 Oxyrane Uk Limited Yeast strains producing mammalian-like complex n-glycans
US20110130465A1 (en) * 2009-12-01 2011-06-02 Nerites Corporation Coatings for prevention of biofilms
WO2011079222A2 (fr) * 2009-12-23 2011-06-30 Boston Scientific Scimed, Inc. Méthode moins traumatique de pose de dispositifs à maillage dans le corps humain
WO2011100460A2 (fr) * 2010-02-11 2011-08-18 Ecole Polytechnique Federale De Lausanne Administration et co-administration de ligands de ccr7 en immunothérapie
US9517250B2 (en) 2010-04-28 2016-12-13 The J. David Gladstone Institutes Methods for generating cardiomyocytes
EP2580242B1 (fr) 2010-06-14 2016-04-06 H. Lundbeck A/S Modulation de l'interaction entre sorla et les récepteurs des ligands de la famille du gdnf
EP2580320B1 (fr) 2010-06-14 2018-08-01 The Scripps Research Institute Reprogrammation de cellules pour leur conférer un nouveau destin
AU2011268458B2 (en) 2010-06-15 2014-06-12 Medgenics Medical Israel Ltd. Long lasting drug formulations
US8808687B2 (en) 2010-07-12 2014-08-19 Mark Humayun Biocompatible substrate for facilitating interconnections between stem cells and target tissues and methods for implanting same
WO2012027494A1 (fr) 2010-08-24 2012-03-01 Regents Of The University Of Minnesota Réactifs bispécifiques de ciblage
US9475709B2 (en) 2010-08-25 2016-10-25 Lockheed Martin Corporation Perforated graphene deionization or desalination
SG189108A1 (en) 2010-09-29 2013-05-31 Oxyrane Uk Ltd Mannosidases capable of uncapping mannose-1-phospho-6-mannose linkages and demannosylating phosphorylated n-glycans and methods of facilitating mammalian cellular uptake of glycoproteins
CN103261432A (zh) 2010-09-29 2013-08-21 奥克西雷恩英国有限公司 磷酸化的n-聚糖的脱甘露糖基化
CN103269708A (zh) 2010-10-01 2013-08-28 Ns基因公司 镍纹蛋白用于治疗异常性疼痛、痛觉过敏、自发性疼痛和幻痛的用途
US9320826B2 (en) 2010-11-09 2016-04-26 Kensey Nash Corporation Adhesive compounds and methods use for hernia repair
CN107823706B (zh) 2010-11-10 2022-02-01 因瑞金公司 用于器官增强的注射制剂
US9149427B2 (en) 2010-12-02 2015-10-06 Neurotech Usa, Inc. Cell lines that secrete anti-angiogenic antibody-scaffolds and soluble receptors and uses thereof
BRPI1008258B1 (pt) * 2010-12-16 2020-03-17 Cellprotect Biotecnologia Ltda - Me Composição biopolimérica para o encapsulamento de células, método de produção de uma composição biopolimérica para o encapsulamento de células, método para promover a citoproteção de células e uso de uma composição biopolimérica para o encapsulamento de células
EP2661255B1 (fr) 2011-01-04 2021-03-10 Brown University Nanotubes utilisés comme transporteurs d'acides nucléiques dans des cellules
US8360765B2 (en) 2011-01-07 2013-01-29 Covidien Lp Systems and method for forming a coaxial implant
FR2972626B1 (fr) 2011-03-16 2014-04-11 Sofradim Production Prothese comprenant un tricot tridimensionnel et ajoure
EP2697650B1 (fr) 2011-04-15 2020-09-30 Dexcom, Inc. Étalonnage avancé de capteur d'échantillon à analyser et détection d'erreur avancée
WO2012149468A2 (fr) 2011-04-29 2012-11-01 University Of Southern California Instruments et procédés d'implantation de substrats ensemencés de cellules
US8877489B2 (en) 2011-12-05 2014-11-04 California Institute Of Technology Ultrathin parylene-C semipermeable membranes for biomedical applications
EP2717899A4 (fr) 2011-06-06 2015-07-29 Kineta One Llc Compositions pharmaceutiques à base de shk et procédés de fabrication et d'utilisation de celles-ci
EP3293197B1 (fr) 2011-06-07 2020-01-08 Wisconsin Alumini Research Foundation Thérapie génique de l'insuline à base d'hépatocytes pour le diabète
FR2977789B1 (fr) 2011-07-13 2013-07-19 Sofradim Production Prothese pour hernie ombilicale
FR2977790B1 (fr) 2011-07-13 2013-07-19 Sofradim Production Prothese pour hernie ombilicale
US20130017264A1 (en) * 2011-07-15 2013-01-17 Piramal Life Sciences Limited Alginate tube drug delivery system and method therefor
WO2013032940A1 (fr) 2011-08-26 2013-03-07 Dexcom, Inc. Membranes polymères pour capteurs de substance à analyser en continu
WO2013034157A1 (fr) 2011-09-05 2013-03-14 Nsgene A/S Traitement de l'allodynie, de l'hyperalgie, de la douleur spontanée et de la douleur illusionnelle
US9526603B2 (en) 2011-09-30 2016-12-27 Covidien Lp Reversible stiffening of light weight mesh
JP2014528406A (ja) 2011-09-30 2014-10-27 ソフラディム・プロダクション 治療薬を送達するための多層インプラント
US20130096170A1 (en) 2011-10-14 2013-04-18 Hospira, Inc. Methods of treating pediatric patients using dexmedetomidine
CA2853379C (fr) 2011-10-27 2020-11-24 Wellstat Ophthalmics Corporation Vecteurs codant pour un facteur de viabilite des cones derive des batonnets
WO2013067195A1 (fr) 2011-11-02 2013-05-10 Halscion, Inc. Méthodes et compositions utilisées pour le traitement des plaies
US9248013B2 (en) 2011-12-05 2016-02-02 California Institute Of Technology 3-Dimensional parylene scaffold cage
TWI590843B (zh) 2011-12-28 2017-07-11 信迪思有限公司 膜及其製造方法
FR2985170B1 (fr) 2011-12-29 2014-01-24 Sofradim Production Prothese pour hernie inguinale
FR2985271B1 (fr) 2011-12-29 2014-01-24 Sofradim Production Tricot a picots
US8242158B1 (en) 2012-01-04 2012-08-14 Hospira, Inc. Dexmedetomidine premix formulation
EP2817014A2 (fr) 2012-02-21 2014-12-31 Baxter International Inc Composition pharmaceutique comportant des cellules cd34+
WO2013136189A2 (fr) 2012-03-15 2013-09-19 Oxyrane Uk Limited Méthodes et substances permettant de traiter la maladie de pompe
AU2013240486B2 (en) 2012-03-27 2017-10-26 Amicus Therapeutics, Inc. Novel compounds for preventing and/or treating lysosomal storage disorders and/or degenerative disorders of the central nervous system
US9744617B2 (en) 2014-01-31 2017-08-29 Lockheed Martin Corporation Methods for perforating multi-layer graphene through ion bombardment
US10653824B2 (en) 2012-05-25 2020-05-19 Lockheed Martin Corporation Two-dimensional materials and uses thereof
US9834809B2 (en) 2014-02-28 2017-12-05 Lockheed Martin Corporation Syringe for obtaining nano-sized materials for selective assays and related methods of use
JP2015519370A (ja) 2012-05-30 2015-07-09 ニューロテック ユーエスエー， インコーポレイテッド 低温保存される植込み型細胞培養デバイスおよびその使用
US9289453B2 (en) * 2012-06-14 2016-03-22 Ramot At Tel-Aviv University Ltd. Transplantation of cells into the nasal cavity and the subarachnoid cranial space
ES2869701T3 (es) 2012-08-01 2021-10-25 United Therapeutics Corp Tratamiento de hipertensión arterial pulmonar con células progenitoras endoteliales tratadas con prostaciclina
JP6901823B2 (ja) 2012-08-01 2021-07-14 ユナイテッド セラピューティクス コーポレイション 間葉系幹細胞による肺動脈性高血圧症の処置
FR2994185B1 (fr) 2012-08-02 2015-07-31 Sofradim Production Procede de preparation d’une couche poreuse a base de chitosane
FR2995788B1 (fr) 2012-09-25 2014-09-26 Sofradim Production Patch hemostatique et procede de preparation
FR2995779B1 (fr) 2012-09-25 2015-09-25 Sofradim Production Prothese comprenant un treillis et un moyen de consolidation
FR2995778B1 (fr) 2012-09-25 2015-06-26 Sofradim Production Prothese de renfort de la paroi abdominale et procede de fabrication
AU2013322268B2 (en) 2012-09-28 2017-08-31 Sofradim Production Packaging for a hernia repair device
US9788765B2 (en) 2012-09-28 2017-10-17 Dexcom, Inc. Zwitterion surface modifications for continuous sensors
CN105377288B (zh) 2012-11-05 2019-11-15 达纳-法伯癌症研究所股份有限公司 Xbp1、cd138和cs1肽的组合物制备药物的用途
CA3177929A1 (fr) 2012-12-21 2014-06-26 Astellas Institute For Regenerative Medicine Procedes de production de plaquettes a partir de cellules souches pluripotentes, et compositions associees
EP2943069B1 (fr) 2013-01-09 2018-08-15 United Therapeutics Corporation Traitement d'une vasculopathie par la prostacycline et des cellules souches mésenchymateuses
US20190040368A1 (en) 2013-03-05 2019-02-07 Oxyrane Uk Limited Production of catalytically active type i sulfatase
EP2964147B1 (fr) 2013-03-07 2018-05-09 Viacyte, Inc. Ensemble de dispositifs d'encapsulation de cellules grande capacité tridimensionnels
USD720469S1 (en) 2013-03-07 2014-12-30 Viacyte, Inc. Cell encapsulation device
WO2014164621A1 (fr) 2013-03-12 2014-10-09 Lockheed Martin Corporation Procédé pour la formation de filtre présentant une ouverture de maille uniforme
US10405961B2 (en) 2013-03-14 2019-09-10 Cell and Molecular Tissue Engineering, LLC Coated surgical mesh, and corresponding systems and methods
US10172791B2 (en) * 2013-03-14 2019-01-08 Massachusetts Institute Of Technology Multi-layer hydrogel capsules for encapsulation of cells and cell aggregates
US9555007B2 (en) 2013-03-14 2017-01-31 Massachusetts Institute Of Technology Multi-layer hydrogel capsules for encapsulation of cells and cell aggregates
US10130288B2 (en) 2013-03-14 2018-11-20 Cell and Molecular Tissue Engineering, LLC Coated sensors, and corresponding systems and methods
DE102013004595A1 (de) 2013-03-15 2014-09-18 Emergent Product Development Germany Gmbh RSV-Impfstoffe
US10376562B2 (en) 2013-03-15 2019-08-13 The Jackson Laboratory Methods for promoting wound healing and hair growth comprising GDNF administration
US9737250B2 (en) 2013-03-15 2017-08-22 Dexcom, Inc. Membrane for continuous analyte sensors
HK1221425A1 (zh) 2013-05-31 2017-06-02 University Of Utah Research Foundation 芋螺毒素(conotoxin)肽，其醫藥組合物和用途
FR3006578B1 (fr) 2013-06-07 2015-05-29 Sofradim Production Prothese a base d’un textile pour voie laparoscopique
FR3006581B1 (fr) 2013-06-07 2016-07-22 Sofradim Production Prothese a base d’un textile pour voie laparoscopique
US20160144067A1 (en) 2013-06-21 2016-05-26 DePuy Synthes Products, Inc. Films and methods of manufacture
US9572918B2 (en) 2013-06-21 2017-02-21 Lockheed Martin Corporation Graphene-based filter for isolating a substance from blood
WO2015042580A1 (fr) 2013-09-23 2015-03-26 Biogen Idec Ma Inc. Compositions et méthodes de traitement d'une douleur neuropathique
SG11201606287VA (en) 2014-01-31 2016-08-30 Lockheed Corp Processes for forming composite structures with a two-dimensional material using a porous, non-sacrificial supporting layer
JP2017510461A (ja) 2014-01-31 2017-04-13 ロッキード マーティン コーポレイションＬｏｃｋｈｅｅｄ Ｍａｒｔｉｎ Ｃｏｒｐｏｒａｔｉｏｎ 広幅イオン場を用いる二次元材料の穿孔
ES2771849T3 (es) 2014-02-12 2020-07-07 Amicus Therapeutics Inc Derivados de azúcares que comprenden restos que contienen azufre, métodos para prepararlos y métodos para emplearlos en el tratamiento de MPS IIIC
AU2015229331A1 (en) 2014-03-12 2016-10-27 Lockheed Martin Corporation Separation membranes formed from perforated graphene
WO2015139051A2 (fr) 2014-03-14 2015-09-17 Rhode Island Hospital Nanovecteurs et leur traitement pour le diagnostic et la thérapeutique
US9675627B2 (en) 2014-04-14 2017-06-13 Amicus Therapeutics, Inc. Dosing regimens for treating and/or preventing cerebral amyloidoses
JP6300287B2 (ja) * 2014-04-14 2018-04-04 学校法人福岡大学 インスリン産生膵島細胞移植用製剤
ES2880948T3 (es) * 2014-05-12 2021-11-26 Roosterbio Inc Células listas para imprimir y dispositivos integrados
US10729579B2 (en) * 2014-07-11 2020-08-04 National Institutes Of Health Surgical tool and method for ocular tissue transplantation
US10080877B2 (en) 2014-07-25 2018-09-25 Warsaw Orthopedic, Inc. Drug delivery device and methods having a drug cartridge
CA2950166C (fr) 2014-07-25 2023-08-01 Becton, Dickinson And Company Dosages d'analyte a l'aide de bandelettes reactives, bandelettes reactives et kits d'utilisation de celles-ci
US9775978B2 (en) 2014-07-25 2017-10-03 Warsaw Orthopedic, Inc. Drug delivery device and methods having a retaining member
AU2015311978A1 (en) 2014-09-02 2017-05-11 Lockheed Martin Corporation Hemodialysis and hemofiltration membranes based upon a two-dimensional membrane material and methods employing same
EP3000489B1 (fr) 2014-09-24 2017-04-05 Sofradim Production Procédé de préparation d'un film barrière anti-adhésion
EP3000433B1 (fr) 2014-09-29 2022-09-21 Sofradim Production Dispositif pour introduire une prothèse pour le traitement de la hernie dans une incision et prothèse textile flexible
EP3000432B1 (fr) 2014-09-29 2022-05-04 Sofradim Production Prothèse à base textile pour le traitement d'une hernie inguinale
CN106999118B (zh) 2014-10-13 2020-07-17 葡萄糖传感器公司 分析物感测装置
EP3029189B1 (fr) 2014-12-05 2021-08-11 Sofradim Production Tricot poreux prothétique, procédé pour son obtention et prothèse à hernie
US9238090B1 (en) 2014-12-24 2016-01-19 Fettech, Llc Tissue-based compositions
EP3059255B1 (fr) 2015-02-17 2020-05-13 Sofradim Production Méthode pour préparer une matrice de chitosane comprenant un élément de renfort fibreux
EP3085337B1 (fr) 2015-04-24 2022-09-14 Sofradim Production Prothèse pour supporter une structure mammaire
JP6850734B2 (ja) 2015-05-27 2021-03-31 ニューロテック ユーエスエー， インコーポレイテッド 眼の障害の処置のためのカプセル化細胞療法の使用
ES2676072T3 (es) 2015-06-19 2018-07-16 Sofradim Production Prótesis sintética que comprende un tejido de punto y una película no porosa y método para formarla
WO2017023376A1 (fr) 2015-08-05 2017-02-09 Lockheed Martin Corporation Feuilles perforables de matériau à base de graphène
JP2018530499A (ja) 2015-08-06 2018-10-18 ロッキード・マーチン・コーポレーション グラフェンのナノ粒子変性及び穿孔
US10179128B2 (en) 2015-08-31 2019-01-15 Amicus Therapeutics, Inc. Regimens for treating and preventing lysosomal disorders and degenerative disorders of the central nervous system
JP6895674B2 (ja) * 2015-10-21 2021-06-30 国立大学法人 東京大学 マイクロチューブ、マイクロチューブの製造方法、及びマイクロチューブの製造装置
ES2959601T3 (es) 2015-10-27 2024-02-27 Univ Queensland Un polipéptido EphA4 modificado
US10076650B2 (en) 2015-11-23 2018-09-18 Warsaw Orthopedic, Inc. Enhanced stylet for drug depot injector
EP3397163B1 (fr) 2015-12-30 2023-09-13 DexCom, Inc. Couche anti-diffusion pour capteurs d'analytes
EP3195830B1 (fr) 2016-01-25 2020-11-18 Sofradim Production Prothèse de réparation de hernie
JP2019517909A (ja) 2016-04-14 2019-06-27 ロッキード・マーチン・コーポレーション 流路を有する二次元膜構造体
EP3442739A4 (fr) 2016-04-14 2020-03-04 Lockheed Martin Corporation Procédé de traitement de feuilles de graphène pour un transfert à grande échelle à l'aide d'un procédé à flottaison libre
WO2017180134A1 (fr) 2016-04-14 2017-10-19 Lockheed Martin Corporation Procédés pour l'utilisation in vivo et in vitro de graphène et d'autres matériaux bidimensionnels
WO2017180135A1 (fr) 2016-04-14 2017-10-19 Lockheed Martin Corporation Membranes à sélectivité ajustable
JP2019519756A (ja) 2016-04-14 2019-07-11 ロッキード・マーチン・コーポレーション 欠陥形成または欠陥修復をその場で監視して制御する方法
SG11201809016QA (en) 2016-04-14 2018-11-29 Lockheed Corp Selective interfacial mitigation of graphene defects
US10871487B2 (en) 2016-04-20 2020-12-22 Glusense Ltd. FRET-based glucose-detection molecules
USD802756S1 (en) 2016-06-23 2017-11-14 Warsaw Orthopedic, Inc. Drug pellet cartridge
EP3272877A1 (fr) 2016-07-18 2018-01-24 ETH Zurich Cellules mimétiques de lymphocyte b
KR20190026786A (ko) 2016-07-18 2019-03-13 에테하 취리히 β-세포-모방 세포
NL2017294B1 (en) 2016-08-05 2018-02-14 Univ Erasmus Med Ct Rotterdam Natural cryptic exon removal by pairs of antisense oligonucleotides.
EP3503914A1 (fr) 2016-08-23 2019-07-03 Oncopep, Inc. Vaccins peptidiques et durvalumab pour le traitement du cancer du sein
WO2018039203A1 (fr) 2016-08-23 2018-03-01 Oncopep, Inc. Vaccins peptidiques et durvalumab pour le traitement du myélome multiple
EP3312325B1 (fr) 2016-10-21 2021-09-22 Sofradim Production Méthode pour la fabrication un treillis avec suture crantée attachée et treillis ainsi obtenu
JP7179723B2 (ja) 2016-10-24 2022-11-29 ユナイテッド セラピューティクス コーポレイション トレプロスチニルによるｍｓｃの免疫調節特性の増強
US10434261B2 (en) 2016-11-08 2019-10-08 Warsaw Orthopedic, Inc. Drug pellet delivery system and method
DK3537986T3 (da) 2016-11-10 2025-07-21 Viacyte Inc Pdx1 pankreatiske endodermceller i celleleveringsanordning
JP6818042B2 (ja) * 2016-11-11 2021-01-20 富士フイルム株式会社 免疫隔離膜、移植用チャンバー、および移植用デバイス
WO2018088451A1 (fr) 2016-11-11 2018-05-17 富士フイルム株式会社 Film d'isolation immunitaire, chambre pour implantation, et dispositif pour implantation
EP3562486B1 (fr) 2016-12-31 2024-03-13 Bioxcel Therapeutics, Inc. Utilisation de dexmédétomidine sublinguale permettant le traitement de l'agitation
CN110573492A (zh) 2017-04-25 2019-12-13 阿米库斯治疗学公司 用于预防和/或治疗中枢神经系统退行性失调和/或溶酶体贮积失调的新颖组合物
EP3398554B1 (fr) 2017-05-02 2025-06-25 Sofradim Production Prothèse pour réparation de hernie inguinale
JP6790266B2 (ja) 2017-06-29 2020-11-25 富士フイルム株式会社 移植用チャンバーおよび移植用デバイス
JP6870087B2 (ja) 2017-06-29 2021-05-12 富士フイルム株式会社 移植用チャンバー、移植用チャンバーの製造方法、移植用デバイス、および多孔質膜の融着方法
JP6790267B2 (ja) 2017-06-29 2020-11-25 富士フイルム株式会社 移植用チャンバーおよび移植用デバイス
US10744313B2 (en) 2017-07-27 2020-08-18 University Of Utah Research Foundation Therapeutic delivery device
AU2018326805B2 (en) 2017-09-01 2023-11-30 Dana-Farber Cancer Institute, Inc. Immunogenic peptides specific to BCMA and TACI antigens for treatment of cancer
US11331022B2 (en) 2017-10-24 2022-05-17 Dexcom, Inc. Pre-connected analyte sensors
EP3700575A1 (fr) 2017-10-24 2020-09-02 Oncopep, Inc. Vaccins peptidiques et pembrolizumab pour le traitement du cancer du sein
US20190120785A1 (en) 2017-10-24 2019-04-25 Dexcom, Inc. Pre-connected analyte sensors
WO2019083960A1 (fr) 2017-10-24 2019-05-02 Oncopep, Inc. Vaccins peptidiques et inhibiteurs d'hdac pour le traitement du myélome multiple
WO2019191151A1 (fr) 2018-03-26 2019-10-03 Rhode Island Hosptial Administration intracellulaire in vitro et in vivo d'arnsi par l'intermédiaire de nano-pièces auto-assemblées
JP7534219B2 (ja) * 2018-04-04 2024-08-14 シギロン セラピューティクス， インコーポレイテッド 移植可能な粒子及び関連方法
MX2020014000A (es) 2018-06-27 2021-06-15 Bioxcel Therapeutics Inc Formulaciones en lámina que contienen dexmedetomidina y métodos para producirlas.
UY38389A (es) * 2018-09-27 2020-04-30 Sigilon Therapeutics Inc Dispositivos implantables para terapia celular y métodos relacionados
US11160791B2 (en) 2018-11-01 2021-11-02 Medefil, Inc. Dexmedetomidine injection premix formulation in ready to use (RTU) bags
EP3653171B1 (fr) 2018-11-16 2024-08-21 Sofradim Production Implants conçus pour la réparation de tissus mous
CA3144606A1 (fr) 2019-06-28 2020-12-30 Mochida Pharmaceutical Co., Ltd. Dispositif de transplantation utilisant de l'acide alginique chimiquement reticule
JP6601931B1 (ja) * 2019-07-17 2019-11-06 株式会社セルファイバ 細胞ファイバ製造システム、細胞ファイバ製造方法及びプログラム
CA3145388A1 (fr) 2019-07-19 2021-01-28 Bioxcel Therapeutics, Inc. Regimes de traitement non sedatifs a base de dexmedetomidine
EP3777827A1 (fr) * 2019-08-14 2021-02-17 MaxiVax SA Capsule implantable
JP7553719B2 (ja) * 2019-09-10 2024-09-18 フンダシオ インスティテュート デ バイオエンジニエリア デ カタルーニャ 多層細胞カプセル及びその使用
US11260146B2 (en) 2019-11-27 2022-03-01 Terumo Medical Corporation Seal-healing valve for a medical instrument
US12064330B2 (en) 2020-04-28 2024-08-20 Covidien Lp Implantable prothesis for minimally invasive hernia repair
CA3202982A1 (fr) 2020-12-22 2022-06-30 Masayuki Shimoda Dispositif de transplantation faisant appel a de l'acide alginique chimiquement reticule
WO2022197982A1 (fr) 2021-03-19 2022-09-22 Dexcom, Inc. Membrane de libération de médicament pour capteur d'analyte
EP4333872A1 (fr) 2021-05-06 2024-03-13 Hoba Therapeutics ApS Prévention et traitement de la douleur neuropathique induite par une chimiothérapie
WO2022240741A1 (fr) 2021-05-12 2022-11-17 Dana-Farber Cancer Institute, Inc. Agents inhibiteurs de lag3 et gal3, peptides xbp1, cs1 et cd138, et leurs méthodes d'utilisation
EP4401634A1 (fr) 2021-09-15 2024-07-24 Dexcom, Inc. Membrane de libération bioactive pour capteur d'analyte
EP4444338A1 (fr) 2021-12-10 2024-10-16 Hoba Therapeutics ApS Traitement de la douleur nociceptive
CA3228457A1 (fr) 2022-02-02 2023-08-10 Dexcom, Inc. Systemes et methodes de detection pour le diagnostic, la stadification, le traitement et l'evaluation de risques de maladie hepatique a l'aide de donnees d'analyte surveillees
EP4482383A1 (fr) 2022-02-23 2025-01-01 Dexcom, Inc. Systèmes et méthodes de détection pour fournir une aide à la décision concernant la santé rénale et/ou le diabète
US20230389833A1 (en) 2022-06-01 2023-12-07 Dexcom, Inc. Systems and methods for monitoring, diagnosis, and decision support for diabetes in patients with kidney disease
JP2025530666A (ja) 2022-09-02 2025-09-17 デックスコム・インコーポレーテッド 連続分析物センサデバイス及び方法
AU2023415722A1 (en) 2022-12-30 2025-07-31 Dexcom, Inc. Sensing systems and methods for hybrid glucose and ketone monitoring
US11806334B1 (en) 2023-01-12 2023-11-07 Bioxcel Therapeutics, Inc. Non-sedating dexmedetomidine treatment regimens
WO2024206928A1 (fr) 2023-03-30 2024-10-03 Pharma Cinq, Llc Vecteur codant un facteur de viabilité de cône dérivé de tige et séquence de signal igk humain
AU2024249858A1 (en) 2023-04-14 2025-09-25 Dexcom, Inc. Sensing systems and methods for providing optimized exercise guidance to healthy hosts and athletes using continuously monitored analyte data
US20240342555A1 (en) 2023-04-14 2024-10-17 Dexcom, Inc. Sensing systems and methods for providing optimized exercise guidance to metabolically unfit hosts using continuously monitored analyte data
US20250049355A1 (en) 2023-08-01 2025-02-13 Dexcom, Inc. Systems and methods for providing therapy management recommendations for diabetic patients and patients with liver disease
DE102023209675A1 (de) * 2023-10-02 2025-04-03 Robert Bosch Gesellschaft mit beschränkter Haftung Verfahren und Vorrichtung für das gezielte Binden einer Matrix einer Zellkultur
US20250213151A1 (en) 2023-12-28 2025-07-03 Dexcom, Inc. Systems and methods for providing therapy management guidance related to liver disease decompensation to users with liver disease
US20250221642A1 (en) 2024-01-05 2025-07-10 Dexcom, Inc. Polymers with dual functionality

Family Cites Families (73)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3093831A (en) * 1959-10-22 1963-06-18 Jordan Gerhard Paul Wilhelm Artificial gland
US3615024A (en) * 1968-08-26 1971-10-26 Amicon Corp High flow membrane
US4324683A (en) * 1975-08-20 1982-04-13 Damon Corporation Encapsulation of labile biological material
US4251387A (en) * 1979-04-17 1981-02-17 Damon Corporation Process for preparing semipermeable microcapsules
US4352883A (en) * 1979-03-28 1982-10-05 Damon Corporation Encapsulation of biological material
US4391909A (en) * 1979-03-28 1983-07-05 Damon Corporation Microcapsules containing viable tissue cells
US4409331A (en) * 1979-03-28 1983-10-11 Damon Corporation Preparation of substances with encapsulated cells
US4298002A (en) * 1979-09-10 1981-11-03 National Patent Development Corporation Porous hydrophilic materials, chambers therefrom, and devices comprising such chambers and biologically active tissue and methods of preparation
US4353888A (en) * 1980-12-23 1982-10-12 Sefton Michael V Encapsulation of live animal cells
NO158284C (no) * 1981-03-13 1988-08-17 Damon Biotech Inc Fremgangsmaate for selektiv oppbrytning av en permeabel membran.
US4407957A (en) * 1981-03-13 1983-10-04 Damon Corporation Reversible microencapsulation of a core material
NO163060C (no) * 1981-03-13 1990-03-28 Damon Biotech Inc Fremgangsmaate for fremstilling av substanser som dannes av levende celler som produserer interferoner eller antistoffer.
NO161446C (no) * 1981-03-13 1989-08-16 Damon Biotech Inc Fremgangsmaate for dyrking av celler som er avhengige av forankring.
JPS59501747A (ja) * 1982-09-29 1984-10-18 スピ−ルバ−グ　セオドア−　イ− カプセル封入された、治療物質産生性の遺伝子操作された生物
US4479796A (en) * 1982-11-15 1984-10-30 Medtronic, Inc. Self-regenerating drug administration device
EP0127989A3 (fr) * 1983-06-01 1986-03-26 Connaught Laboratories Limited Micro-encapsulation de tissu vivant et de cellules
US4806355A (en) * 1983-06-06 1989-02-21 Connaught Laboratories Limited Microencapsulation of living tissue and cells
US4689293A (en) * 1983-06-06 1987-08-25 Connaught Laboratories Limited Microencapsulation of living tissue and cells
EP0147939A2 (fr) * 1983-11-15 1985-07-10 JOHNSON & JOHNSON Module implantable pour la régulation de la glycémie
US4663286A (en) * 1984-02-13 1987-05-05 Damon Biotech, Inc. Encapsulation of materials
US4749620A (en) * 1984-02-15 1988-06-07 Massachusetts Institute Of Technology Encapsulated active material system
FR2559780B1 (fr) * 1984-02-21 1990-05-04 Tech Cuir Centre Systemes biocompatibles implantables a base de collagene permettant la conservation et/ou la culture cellulaires et/ou la liberation controlee de principes actifs
US4686098A (en) * 1984-05-14 1987-08-11 Merck & Co., Inc. Encapsulated mouse cells transformed with avian retrovirus-bovine growth hormone DNA, and a method of administering BGH in vivo
CA1215922A (fr) * 1984-05-25 1986-12-30 Connaught Laboratories Limited Microencapsulation de cellules et de tissus vivants
DE3506288A1 (de) * 1984-09-06 1986-03-13 Johannes 7900 Ulm Reinmüller Vorrichtung zum einlegen in wunden und wundhoehlen
GB8500121D0 (en) * 1985-01-03 1985-02-13 Connaught Lab Microencapsulation of living cells
US4868121A (en) * 1985-02-07 1989-09-19 Mcdonnell Douglas Corporation Islet isolation process
US4663288A (en) * 1985-05-22 1987-05-05 Nabisco Brands, Inc. Process for purification of enzymes
US4997443A (en) * 1985-08-26 1991-03-05 Hana Biologics, Inc. Transplantable artificial tissue and process
US4902295A (en) * 1985-08-26 1990-02-20 Hana Biologics, Inc. Transplantable artificial tissue
US4976709A (en) * 1988-12-15 1990-12-11 Sand Bruce J Method for collagen treatment
DE3545237A1 (de) * 1985-12-20 1987-06-25 Juergen Dr Med Schrezenmeir Vorrichtung fuer die aufnahme und zum einbringen von geweben in den menschlichen koerper sowie hierfuer verwendbares instrument
DE3681572D1 (de) * 1985-12-26 1991-10-24 Taiho Pharmaceutical Co Ltd Weiche nahtlose kapseln.
WO1987004367A1 (fr) * 1986-01-23 1987-07-30 Ltl Associates Membranes covalentes
IL79052A0 (en) * 1986-06-06 1986-11-30 Univ Ramot Device and process for production of alginate-shell beads containing biologically active material
AU7646087A (en) * 1986-06-27 1988-01-29 Damon Biotech Inc. Covalent membranes
US4883666A (en) * 1987-04-29 1989-11-28 Massachusetts Institute Of Technology Controlled drug delivery system for treatment of neural disorders
US5026365A (en) * 1987-04-29 1991-06-25 The University Of Massachusetts Method and apparatus for therapeutically treating immunological disorders and disease states
US4911717A (en) * 1987-06-18 1990-03-27 Gaskill Iii Harold V Intravasular artificial organ
US4942129A (en) * 1987-07-28 1990-07-17 Queen's University At Kingston Multiple membrane microencapsulation
GB2212067B (en) * 1987-11-12 1991-08-07 Michael Robin Baugh Board game apparatus
US5283187A (en) * 1987-11-17 1994-02-01 Brown University Research Foundation Cell culture-containing tubular capsule produced by co-extrusion
US4892538A (en) * 1987-11-17 1990-01-09 Brown University Research Foundation In vivo delivery of neurotransmitters by implanted, encapsulated cells
US5156844A (en) * 1987-11-17 1992-10-20 Brown University Research Foundation Neurological therapy system
US5106627A (en) * 1987-11-17 1992-04-21 Brown University Research Foundation Neurological therapy devices
US5182111A (en) * 1987-11-17 1993-01-26 Boston University Research Foundation In vivo delivery of active factors by co-cultured cell implants
US5158881A (en) * 1987-11-17 1992-10-27 Brown University Research Foundation Method and system for encapsulating cells in a tubular extrudate in separate cell compartments
GB2211103A (en) * 1987-12-18 1989-06-28 Flaxman Binns Frances Julia Toy or games equipment
US5011472A (en) * 1988-09-06 1991-04-30 Brown University Research Foundation Implantable delivery system for biological factors
US5011486A (en) * 1988-11-18 1991-04-30 Brown University Research Foundation Composite nerve guidance channels
US5082670A (en) * 1988-12-15 1992-01-21 The Regents Of The University Of California Method of grafting genetically modified cells to treat defects, disease or damage or the central nervous system
DK0478671T3 (da) * 1989-06-21 1993-10-18 Univ Brown Res Found Neurologisk terapeutisk anordning
WO1991000119A1 (fr) * 1989-06-30 1991-01-10 Baxter International Inc. Dispositif implantable
DE59005380D1 (de) * 1989-07-01 1994-05-19 Zahnradfabrik Friedrichshafen Rückschaltsicherung.
US5002661A (en) * 1989-08-25 1991-03-26 W. R. Grace & Co.-Conn. Artificial pancreatic perfusion device
DE69030435D1 (de) * 1989-09-04 1997-05-15 Fujitsu Ltd Relaisvermittlungsanlage für zeitmultiplexdaten
GB2238059A (en) * 1989-11-17 1991-05-22 Command International Inc Electrolytic gas generating apparatus for producing a combustible mixture of hydrogen and oxygen by electrolysis of water for particular use in gas welding
EP0502949A4 (en) * 1989-12-05 1993-02-24 Trancel Corporation Homologous guluronic acid alginate coating composition for in-vivo application and implantation and method of using same
WO1991009119A1 (fr) * 1989-12-13 1991-06-27 Trancel Corporation Microcapsules d'alginate ameliorees et procedes pour leur fabrication et leur utilisation
WO1991010470A1 (fr) * 1990-01-08 1991-07-25 Brown University Research Foundation Dispositifs et procedes d'apport ameliore de facteurs actifs
US5084350A (en) * 1990-02-16 1992-01-28 The Royal Institution For The Advance Of Learning (Mcgill University) Method for encapsulating biologically active material including cells
AU651654B2 (en) * 1992-01-14 1994-07-28 Endo Pharmaceuticals Solutions Inc. Manufacture of water-swellable hydrophilic articles and drug delivery devices
ATE138256T1 (de) * 1990-10-31 1996-06-15 Baxter Int Vaskularisation erlaubendes implantatmaterial
US5144069A (en) * 1990-12-13 1992-09-01 Minnesota Mining And Manufacturing Company Process for the preparation of fluoroaliphatic aminocarboxylate surfactants
US5158844A (en) * 1991-03-07 1992-10-27 The Dexter Corporation Battery separator
ES2107537T3 (es) * 1991-04-25 1997-12-01 Univ Brown Res Found Vehiculo inmunoaislante biocompatible implantable para suministrar productos terapeuticos seleccionados.
DE69223932T2 (de) * 1991-06-28 1998-05-28 Univ Brown Res Found Kapselextrusionssysteme
AU663103B2 (en) * 1991-06-28 1995-09-28 Brown University Research Foundation Neural implant system
FI935871L (fi) * 1991-06-28 1993-12-27 Univ Brown Res Found Utbytbar implanterbar neural anordning samt foerfarande
AU2502592A (en) * 1991-08-23 1993-03-16 Denise Faustman Implantable immunoisolated therapeutic devices
WO1993022427A1 (fr) * 1992-04-24 1993-11-11 Somatix Therapy Corporation Procede de culture de cellules viables et procede de regulation du niveau d'un compose dans un fluide corporel
AU4114993A (en) * 1992-04-24 1993-11-29 Polymer Technology Group, Inc., The Biocompatible, therapeutic, implantable device
BE1009510A5 (nl) * 1995-07-24 1997-04-01 Dijk Aart Van Programmeerbare logische besturingseenheid.

Also Published As

Publication number Publication date
EP0585368A4 (fr) 1994-04-13
JPH06507412A (ja) 1994-08-25
CA2109085C (fr) 2003-03-11
US5798113A (en) 1998-08-25
GR3025301T3 (en) 1998-02-27
FI934545A7 (fi) 1993-12-01
AU3902095A (en) 1996-02-01
DE69221484T2 (de) 1998-02-19
ATE156344T1 (de) 1997-08-15
FI934545A0 (fi) 1993-10-14
US20020150603A1 (en) 2002-10-17
JP2007314569A (ja) 2007-12-06
US6960351B2 (en) 2005-11-01
US5834001A (en) 1998-11-10
NO308198B1 (no) 2000-08-14
HK1001832A1 (en) 1998-07-10
SG47470A1 (en) 1998-04-17
US6083523A (en) 2000-07-04
NO933842L (no) 1993-10-25
US6322804B1 (en) 2001-11-27
EP0585368A1 (fr) 1994-03-09
US20040185083A1 (en) 2004-09-23
AU2004192A (en) 1992-12-21
WO1992019195A1 (fr) 1992-11-12
JP4215273B2 (ja) 2009-01-28
ES2107537T3 (es) 1997-12-01
US5871767A (en) 1999-02-16
CA2109085A1 (fr) 1992-10-26
EP0585368B1 (fr) 1997-08-06
US5874099A (en) 1999-02-23
DE69221484D1 (de) 1997-09-11
AU666118B2 (en) 1996-02-01
AU682796B2 (en) 1997-10-16
US5869077A (en) 1999-02-09
US5800828A (en) 1998-09-01

Similar Documents

Publication Publication Date Title
DK0585368T3 (da) Implanterbart biokompatibelt immunisolatorisk vehikel til afgivelse af udvalgte terapeutiske produkter
US6372244B1 (en) Retrievable bioartificial implants having dimensions allowing rapid diffusion of oxygen and rapid biological response to physiological change, processes for their manufacture, and methods for their use
SG48813A1 (en) Improved composition and methods for the delivery of biologically active molecules using genetically altered cells contained in biocompatible immunoisolatory capsules
AU582920B2 (en) Continuous release pharmaceutical compositions
EP0301856A3 (en) Delivery system
ATE79024T1 (de) Implantate zur abgabe biologisch aktiver makromolekuele.
IL134009A (en) Transplant device
DK0702563T3 (da) Sammensætninger og fremgangsmåder til behandling af cancer og hyperproliferative sygdomme
EP0127989A3 (fr) Micro-encapsulation de tissu vivant et de cellules
DE2967036D1 (en) Vaccine and method of making
Alcaraz et al. Tackling the concept of symbiotic implantable medical devices with nanobiotechnologies
Rokstad et al. Transplantation of alginate microcapsules with proliferating cells in mice: capsular overgrowth and survival of encapsulated cells of mice and human origin
CA2250880A1 (fr) Cellules contenant des billes d'agarose-collagene implantables, qui produisent un produit biologique diffusible, et leurs utilisations
AU7479596A (en) Induction of immunological tolerance
King et al. The role of capsule composition and biologic responses in the function of transplanted microencapsulated islets of langerhans1
AU605159B2 (en) Improved mammal immunization
Kindred et al. Survival and activity of congenic and allogeneic thymus cell suspensions in nude mice
Payte The use of insulin in the treatment of diabetes: An analogy to methadone maintenance
MD1682G2 (ro) Metodă de imunoterapie în pneumonii trenante la copii
Kaplan et al. Interferon-gamma production: an in vitro model utilizing cell encapsulation technology
UA22019A (uk) Спосіб визhачеhhя цитотоксичhості отрути блідої погаhки
Rollins-Smith et al. Immune responses of intact and embryonically enucleated frogs to self-lens antigens
Jara et al. Sequential co-transplantation of hepatic cells and pancreatic islets in wistar rats with long-evans or wistar rats as recipients
Favrot et al. Correspondence re: John R. Yanelli et al., Enhancement of Human Lymphokine-activated Killer Cell Cytolysis and a Method for Increasing Lymphokine-activated Killer Cell Yields to Cancer Patients. Cancer Res., 48: 5696-5700, 1988
Wang Property and biocompatibility of alginate-based gel beads and microcapsules